- Datum21.04.2025
- Uhrzeit19:00 - 20:00 Uhr
- Veranstalter
BNP Paribas
Co-Diagnostics Inc. Aktie
Verkaufen
Kaufen
Co-Diagnostics Inc. Chart
Co-Diagnostics Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
3,09 %
Intraday
-5,85 %
1 Woche
-21,22 %
1 Monat
-53,68 %
Seit Jahresbeginn
-70,05 %
1 Jahr
-93,37 %
3 Jahre
-97,35 %
5 Jahre
Passender Service zu Co-Diagnostics Inc.
Webinar zu Co-Diagnostics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,280-2,230
- Jahrestief / Hoch ($)0,280-1,070
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Co-Diagnostics Inc.
Keine Dividenden verfügbar
Termine von Co-Diagnostics Inc.
Keine aktuellen Termine
Beschreibung
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
